EW
$86.45 · +1.4% today · +0.8% 5d · −1.6% 3m · +18.5% 1y
Daily score17
Weekly score22
Long-term score62
Close
Scores (0–100)
Components — latest (2026-10-14)
Close
86.45
1D return
+1.4%
5D return
+0.8%
Rel volume
1.07
CMF 20
0.00
OBV slope 20
-0.04
Up-vol ratio 10
0.39
Short ratio
0.65
Short ratio Δ
+16.1%
Persistence 10
0.00
Inflow mean 5d
-0.35
Inflow mean 60d
0.04
Momentum 12-1
+17.5%
% of 52w high
+90.8%
vs 200d
+1.5%
Volatility 60d
+22.9%
Dollar vol 20d
$323.16M
Insider buys 90d
$0
Insider buyers 90d
0.00
Revenue growth
+13.6%
Fundamentals — Edwards Lifesciences · Health Care
as of 2026-10-22- P/E
- 48.4
- P/B
- 4.89
- ROE
- 10.1%
- Operating margin
- 20.8%
- Debt / equity
- 0.06
- FCF yield
- 2.6%
- Years profitable
- 5/5
- BM score
- 16
- Moat flag
- No
Insider trades (Form 4)
| Filed | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-10-08 | Lippis Daniel J. | CVP, TAVR | Sell | 619 | $85.65 | $53.0K |
| 2026-09-11 | Lippis Daniel J. | CVP, TAVR | Sell | 619 | $87.51 | $54.2K |
| 2026-08-31 | Dahl Andrew M. | SVP, Corporate Controller | Sell | 544 | $91.06 | $49.5K |
| 2026-08-28 | Bruls Annette | CVP, EMEACLA | Sell | 2.6K | $89.98 | $237.9K |
| 2026-08-26 | Chopra Daveen | CVP, TMTT, Surgical & IHFM | Sell | 1.2K | $91.76 | $105.9K |
| 2026-08-26 | Markowitz Wayne | CVP, JAPAC | Sell | 1.2K | $91.47 | $113.4K |
| 2026-08-26 | Chopra Daveen | CVP, TMTT, Surgical & IHFM | Sell | 30.6K | $90.99 | $2.79M |
| 2026-08-11 | Lippis Daniel J. | CVP, TAVR | Sell | 619 | $92.03 | $57.0K |
| 2026-07-30 | Markowitz Wayne | CVP, JAPAC | Sell | 146 | $86.03 | $12.6K |
| 2026-07-28 | Markowitz Wayne | CVP, JAPAC | Sell | 9.6K | $85.06 | $819.0K |
| 2026-07-27 | Zovighian Bernard J | CEO | Sell | 2.9K | $83.93 | $245.1K |
| 2026-07-10 | Lippis Daniel J. | CVP, TAVR | Sell | 619 | $91.70 | $56.8K |
| 2026-06-30 | Lippis Daniel J. | CVP, TAVR | Sell | 619 | $91.40 | $56.6K |
| 2026-06-17 | Zovighian Bernard J | CEO | Sell | 523 | $87.92 | $46.0K |
| 2026-05-29 | Dahl Andrew M. | SVP, Corporate Controller | Sell | 568 | $86.08 | $48.9K |
| 2026-05-27 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 23.1K | $86.42 | $2.00M |
| 2026-05-22 | Chopra Daveen | CVP, TMTT & Surgical | Sell | 1.5K | $84.60 | $126.9K |
| 2026-05-18 | Lippis Daniel J. | CVP, TAVR | Sell | 620 | $81.14 | $50.3K |
| 2026-05-18 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 8.0K | $81.82 | $654.6K |
| 2026-05-18 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 10.0K | $82.07 | $818.1K |
| 2026-05-12 | Zovighian Bernard J | CEO | Sell | 35.5K | $77.92 | $2.77M |
| 2026-05-12 | Zovighian Bernard J | CEO | Sell | 845 | $78.40 | $66.2K |
| 2026-05-11 | Markowitz Wayne | CVP, JAPAC | Sell | 593 | $79.73 | $47.3K |
| 2026-05-04 | Lippis Daniel J. | CVP, TAVR | Sell | 1.0K | $82.99 | $83.0K |
| 2026-05-04 | Lippis Daniel J. | CVP, TAVR | Sell | 1.0K | $83.98 | $85.6K |
| 2026-05-04 | Lippis Daniel J. | CVP, TAVR | Sell | 19 | $83.99 | $1.6K |
Congress trades
| Filed | Traded | Member | Type | Owner | Amount | Lag | Source |
|---|---|---|---|---|---|---|---|
| 2025-12-29 | 2025-11-19 | Josh Gottheimer (NJ05) | Sale | Joint | $1,001 - $15,000 | 40 |
Source: U.S. House Clerk periodic transaction reports (STOCK Act). Disclosures lag trades.